-- 独立研究机构CFRA向提供了以下研究报告。CFRA分析师总结如下： CF Industries第一季度业绩强劲，每股收益（EPS）为3.98美元，高于去年同期的1.85美元，也高于市场普遍预期的2.66美元；调整后EBITDA增长53%至9.83亿美元，也高于市场普遍预期的7.74亿美元。净销售额增长19%至19.9亿美元，超过市场普遍预期的18.6亿美元，这主要得益于各业务板块强劲的定价策略抵消了Yazoo City工厂停产造成的销量下降。卓越的运营执行力（氨产能利用率高达99%）以及在全球氮肥市场受限的情况下所采取的战略定位，都为该投资标的提供了有力支撑。管理层预计2026年全年氨总产量约为950万吨，亚祖城项目预计要到2026年第四季度末才能恢复生产。鉴于中东冲突导致50%-60%的区域产能受到影响，以及液化天然气供应受限影响依赖进口的地区，我们预计全球供需平衡紧张的局面将持续。CF的低碳举措，包括与Blue Point的合资企业和亚祖城碳捕集与封存（CCS）项目，为长期价值创造提供了结构性优势。
Related Articles
Australia
CVS Health Increasingly Likely to Reach 3% Medicare Advantage Target Margin in 2028, RBC Says
CVS Health (CVS) is increasingly more likely to reach its 3% Medicare Advantage target margin in 2028, RBC Capital Markets analyst said in a note Wednesday.Analysts said the company's Q1 adjusted earnings "comfortably" beat expectations, driven by "strong" topline growth and a notable improvement in profitability in the Health Care Benefits segment.Medical costs came in below expectations and, while the company maintained its medical benefit ratio guidance for the year, it is increasingly likely to outperform, according to the note.The brokerage raised its 2026 adjusted earnings estimate for the company to $7.41 from $7.10. Analysts surveyed by FactSet expect $7.29.RBC reiterated its outperform rating on the stock and increased its price target to $107 from $93.Price: $87.01, Change: $+0.14, Percent Change: +0.17%
$CVS
Research
Research Alert: CFRA Maintains Strong Buy Rating On Shares Of Trimble Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We increase our target price to $86, from 85, on a forward P/E of 21x our 2027 EPS projection of $4.08, below historical averages. We increase our 2026 EPS projection to $3.59 from $3.52, and lift our 2027 EPS estimate to $4.08 from $4.06. TRMB reported solid Q1 beats with revenue of $939.9M, up 12% Y/Y, led by AECO at 14% organic revenue and ARR growth, Field Systems posting 12% growth, and Transportation & Logistics growing 7% despite freight market headwinds. ARR reached a record $2.435B, up 13% organically, reinforcing business model durability. Non-GAAP operating margin improved 230 bps to 25.9%, while non-GAAP gross margins expanded 180 bps to 71.0%, and we see continued margin expansion as its subscription revenues scale. We note steady execution in its core business, while building AI momentum through new products and partnerships with AI labs. Management reaffirmed its 2027 targets, supporting our positive view, though macro risks warrant monitoring.
$TRMB
Australia
Apollo Global Trades at Lower Discount Versus Peers, RBC Says
Apollo Global Management (APO) shares are trading in-line with historical average multiple and at a lower discount against its peers, RBC Capital Markets said in a Thursday note."We maintain our Sector Perform rating largely driven by relative valuation," the report said.The note said its Q1 performance was characterized by strong fee-related earnings growth, offset by weak spread-related earnings growth, driving a low adjusted net income per share growth.RBC raised its price target to $146 from $139 on rolling forward its valuation and higher estimates.Price: $127.33, Change: $-2.20, Percent Change: -1.70%
$APO